Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: A stable isotope study

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1801-1807

  Christ, E R ^a   Cummings, M H ^b   Jackson, N ^b   Stolinski, M ^b   Lumb, P J ^b   Wierzbicki, A S ^b   Sonksen P H ^b   Russell Jones, D L ^b   Umpleby, A M ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; CARBON 13; HUMAN GROWTH HORMONE; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEART PROTECTION; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; INTERMETHOD COMPARISON; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN METABOLISM; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; SHORT COURSE THERAPY;

APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; BODY COMPOSITION; CARBON ISOTOPES; DOUBLE-BLIND METHOD; FEMALE; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KINETICS; LIPIDS; LIPOPROTEINS, LDL; MALE; METABOLISM, INBORN ERRORS;

EID: 1942440823     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031474     Document Type: Article

References (55)

1. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
2. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
3. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA 1994 Serum lipid levels in growth hormone-deficient men. Metabolism 43:199-203
4. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R, Johnston DG 1994 Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol 130:451-458
5. al-Shoumer KA, Anyaoku V, Richmond W, Johnston DG 1997 Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 47:153-159
6. Cummings MH, Christ E, Umpleby AM, Albany E, Wierzbicki A, Lumb PJ, Sonksen PH, Russell-Jones DL 1997 Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. J Clin Endocrinol Metab 82:2010-2013
7. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195-200
8. Grundy SM 1997 Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95:1-4
9. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, Fazio S, Di Rella F, Biondi B, Lombardi G, Sacca L 1997 Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 82:1378-1381
10. O'Neal D, Hew FL, Sikaris K, Ward G, Alford F, Best JD 1996 Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. J Clin Endocrinol Metab 81:2448-2454
11. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
12. Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR, Sonksen PH 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 41:345-350
13. Beshyah SA, Henderson A, Niththyananthan R, Skinner E, Anyaoku V, Richmond W, Sharp P, Johnston DG 1995 The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 80:356-363
14. Christ ER, Cummings MH, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Naoumova RP, Boroujerdi MA, Sonksen PH, Russell-Jones DL 1999 Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. J Clin Endocrinol Metab 84:307-316
15. Hew FL, O'Neal D, Kamarudin N, Alford FP, Best JD 1998 Growth hormone deficiency and cardiovascular risk. Baillieres Clin Endocrinol Metab 12:199-216
16. O'Neal DN, Hew FL, Best JD, Alford F 1999 The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy. Growth Horm IGF Res 9:165-173
17. Kearney T, de Gallegos CN, Proudler A, Parker K, Anayaoku V, Bannister P, Venkatesan S, Johnston DG 2003 Effects of short-and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects. Metabolism 52:50-59
18. Packard CJ 1995 The role of stable isotopes in the investigation of plasma lipoprotein metabolism. Baillieres Clin Endocrinol Metab 9:755-772
19. Rudling M, Parmi P, Angelin B 1999 Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans. Growth Horm IGF Res 9(Suppl A):1-7
20. Parmi P, Angelin B, Lobie PE, Norstedt G, Rudling M 1995 Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology 136:3767-3773
21. Parini P, Angelin B, Rudling M 1999 Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 19:832-839
22. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B 1992 Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89:6983-6987
23. Matthews DE, Schwarz HP, Yang RD, Motil KJ, Young VR, Bier DM 1982 Relationship of plasma leucine and α-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31:1105-1112
24. 1973 Standard techniques for the measurement of red-cell and plasma volume. A report by the International Committee for Standardization in Haematology (ICHS): Panel on Diagnostic Applications of Radioisotopes in Haematology. Br J Haematol 25:801-814
25. Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sonksen PH 1995 Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis 113:79-89
26. Menand C, Pouteau E, Marchini S, Maugere P, Krempf M, Darmaun D 1997 Determination of low 13C-glutamine enrichments using gas chromatography- combustion-isotope ratio mass spectrometry. J Mass Spectrom 32:1094-1099
27. Cummings MH, Watts GF, Lumb PJ, Slavin BM 1994 Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma. J Clin Pathol 47:176-178
28. Sönksen PH 1976 Double antibody technique for the simultaneous assay of insulin and growth hormone. In: Antoniades IH, ed. Hormones in human blood: detection assay. Cambridge, MA: Harvard University Press; 176-199
29. Teale JD, Marks V 1990 Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor 1 in the diagnosis of non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) 33:87-98
30. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ 1990 Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest 85:804-811
31. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 42:1519-1523
32. Kearney T, Navas de Gallegos C, Chrisoulidou A, Gray R, Bannister P, Venkatesan S, Johnston DG 2001 Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein. J Clin Endocrinol Metab 86:3900-3906
33. Chrisoulidou A, Kousta E, Venkatesan S, Gray R, Bannister PA, Gallagher JJ, Lawrence N, Johnston DG 2000 Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism. Metabolism 49:563-566
34. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52
35. Christ E, Cummings M, Russell-Jones D 1998 Dyslipidaemia in adult growth hormone deficiency and the effect of GH replacement therapy - a review. Trends Endocrinol Metab 9:200-206
36. Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP 2000 Effect of growth hormone replacement therapy on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone-deficient adults. J Lipid Res 41:925-932
37. Fowelin J, Attvall S, Lager I, Bengtsson BA 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443-1447
38. Danesh J, Collins R, Peto R 2000 Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102:1082-1085
39. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
40. Johannsson G, Oscarsson J, Rosen T, Wiklund O, Olsson G, Wilhelmsen L, Bengtsson BA 1995 Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes. Arterioscler Thromb Vasc Biol 15:2142-2150
41. Garry P, Collins P, Devlin JG 1996 An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol 134:61-66
42. Meddings JB, Dietschy JM 1986 Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man. Circulation 74:805-814
43. ter Maaten JC, Voorburg A, de Vries PM, ter Wee PM, Donker AJ, Gans RO 1998 Relationship between insulin's haemodynamic effects and insulin-mediated glucose uptake. Eur J Clin Invest 28:279-284
44. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH 1991 Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 70:695-700
45. Christ ER, Cummings MH, Westwood NB, Sawyer BM, Pearson TC, Sonksen PH, Russell-Jones DL 1997 The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metab 82:2985-2990
46. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC 1996 Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 98:2706-2713
47. Christ ER, Chowienczyk PJ, Sonksen PH, Russel-Jones DL 1999 Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity. Clin Endocrinol (Oxf) 51:21-25
48. ter Maaten JC, de Boer H, Kamp O, Stuurman L, van der Veen EA 1999 Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 84:2373-2380
49. Pietzsch J, Lattke P, Julius U 2000 Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies. Arterioscler Thromb Vasc Biol 20:E63-E67
50. Mackness MI, Durrington PN 1995 Paraoxonase: another factor in NIDDM cardiovascular disease. Lancet 346:856
51. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D 2000 Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41:305-318
52. Parhofer KG, Hugh P, Barrett R, Bier DM, Schonfeld G 1991 Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res 32:1311-1323
53. Johnston DG, Alberti KG, Nattrass M, Barnes AJ, Bloom SR, Joplin GF 1980 Hormonal and metabolic rhythms in Cushing's syndrome. Metabolism 29: 1046-1052
54. Staub JJ 1998 Minimal thyroid failure: effects on lipid metabolism and peripheral target tissues. Eur J Endocrinol 138:137-138
55. Ley CJ, Lees B, Stevenson JC 1992 Sex-and menopause-associated changes in body-fat distribution. Am J Clin Nutr 55:950-954